PHARMACEUTICAL COMPOSITION OF PROLONGED RELEASE, FORM OF SOLID DOSAGE FOR EXTENDED RELEASE, AND, METHOD. The invention relates to a sustained release formulation for delivering or more pharmaceutically active agents. The formulation comprises high amylose cross-linked starch and at least one pharmaceutically active agent, and optionally may be subdivided into smaller dosage forms, where smaller dosage forms have substantially the same sustained release properties as the formulation from which they were derived. . The formulations may provide sustained release for up to at least 24 hours, and by virtue of their divisibility, permits an active agent container or the person administering the active agent to titrate the dosage of the agent.
展开▼